Administration of sting agonist and checkpoint inhibitors
TW202626063APending Publication Date: 2026-07-01TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114132231
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-03-26
- Filing Date
- 2020-07-09
- Publication Date
- 2026-07-01
Abstract
The present disclosure provides methods, pharmaceutical compositions, and kits for treating cancer in patients in need thereof. The methods comprise administering to a patient in need a STING (stimulator of interferon genes) agonist, such as Compound No. 14 as defined in the description, or a pharmaceutically acceptable salt thereof, in combination with one or more checkpoint inhibitors. Also provided are medicaments for use in treating cancer.
Need to check novelty before this filing date? Find Prior Art